Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02402517
Other study ID # B2014:114-2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2015
Est. completion date December 2017

Study information

Verified date May 2017
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives are to test the acute effects of different extruded pulse snacks on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite on an aerobic exercise session, and 3) food intake two hours following the exercise session. The investigators hypothesize that consumption of food products containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. The investigators also hypothesize that consumption of extruded pulse snacks will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Normoglycemic (<5.6 mmol/L) and normotensive (systolic blood pressure <140 mm Hg and diastolic blood pressure below < 90 mm Hg) - BMI of 18.5-29.9 kg/m2 Exclusion Criteria: - Restrained eaters - Regularly skip breakfast - Smokers - Those who are active (organized activities or athletic training at a high intensity; = 150 min per week of moderate to vigorous physical activity) - Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year. - Those unable to walk for an hour continuously

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Control
Non pulse extruded snack
Small particle size pea flour
Pulse extruded snack
Large particle size pea flour
Pulse extruded snack
Lentil flour
Pulse extruded snack
Navy bean flour
Pulse extruded snack
Pinto bean flour
Pulse extruded snack

Locations

Country Name City State
Canada Richardson Centre for Functional Foods and Nutraceuticals Winnipeg Manitoba

Sponsors (3)

Lead Sponsor Collaborator
University of Manitoba Alberta Pulse Growers, Saskatchewan Pulse Growers

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Plasma Glucose and Insulin Concentrations Measured in blood using intravenous catheter at 14 time points, used to calculate area under curve (AUC). Glucose will be determined by automated methods using Abbot Spectrum CCX Analyzer, and Insulin will be measured by commercially available RIA kits. (Composite measure) 0 - 240 min
Primary Food Intake Ad-libitum meal. Food consumed measured by weight. at 120 min
Primary Subjective Appetite Measured by VAS questionnaire at 14 time points, used to calculate area under curve (AUC).( Composite measure) 0-240 min
Primary Exercise intensity Sixty minute exercise protocol at minutes 60 to 120. Oxygen consumption measured during exercise at 3 time points. 60 minutes
Secondary Lactate concentration 60 minute exercise protocol at minutes 60 to 120. Measured before, during, and exercise exercise at 3 time points 60 minutes
Secondary Palatability of treatments Measured by VAS questionnaire at 5 minutes
Secondary Palatability of meal Measured by VAS questionnaire at 260 minutes
Secondary Physical comfort Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure) 0-240 min
Secondary Energy/fatigue Measured by VAS questionnaire at 13 time points, used to calculate area under curve (AUC) (Composite measure) 0-240 min
Secondary Heart rate Heart rate monitored over a 60 minute exercise protocol. To monitor exercise intensity and give a measure of fatigue (cardiovascular drift) 60-120 min
Secondary Substrate Oxidation Measured during 60 minute exercise protocol at minutes 60-120. Respiratory quotient measured during exercise at 3 time points. 60 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2